Related by context. Frequent words. (Click for all words.) 49 Phase 1a 47 registrational trial 47 Phase 45 PWM controller 45 Phase II 45 eniluracil 45 orally bioavailable 45 Phase 1b 45 GV# [001] 44 liposomal formulation 44 multiple ascending dose 43 Amigal 43 phase IIa 43 IND submission 43 1a 43 DB# [003] 43 TG# [001] 42 phase IIb 42 MAP# 42 msec 42 IIb 42 Phase 2a trial 42 Phase III 42 Phase 2b trial 42 phenotyping 42 OXi# 42 Clinical Trial Results 41 GRN#L 41 ozarelix 41 ATL# [001] 41 Phase Ib clinical 41 elotuzumab 41 Pivotal Trial 41 unblinding 41 confirmatory Phase III 41 OncoVEX GM CSF 41 blinatumomab 41 SparVax TM 41 RG# [001] 41 DDP# 41 sinusoidal 41 Pivotal Phase 41 ZFP Therapeutic 41 PK PD 41 AP# [003] 41 Azedra 41 dose escalation 41 IIa 41 dose escalation trial 41 BLA submission 41 Metastatic Melanoma 41 ADVENT 40 registrational 40 kinase inhibitor 40 custirsen 40 tanespimycin 40 Pivotal Phase III 40 HspE7 40 ascending doses 40 drug conjugate 40 Sym# 40 Phase III Clinical Trial 40 Phase Ib 40 Phases II 40 γ 40 nab paclitaxel 40 placebo controlled Phase 40 Phase 2b clinical 40 dose limiting toxicities 40 Monotherapy 40 Traficet EN 40 sapacitabine 40 PS# [001] 40 lytic 40 MGCD# [001] 40 Agilent N#A 40 IIa clinical trial 40 prospective multicenter 40 BNC# 40 TASQ 39 tumor antigen 39 IIIB 39 GSK# [001] 39 pharmacodynamic effects 39 MSC# [001] 39 KNS # 39 Calibrated 39 XL# [003] 39 deforolimus 39 MIRCERA 39 phase 39 RIBBON 39 IIIA 39 IMC A# 39 Phase 2a 39 BrachySil 39 PF # [001] 39 phase IIb clinical 39 dose cohorts 39 dose titration 39 EPC#